GENE THERAPY OF CANCEROUS DISEASES
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2015, Vol 7, Issue 6
Abstract
Gene therapy of cancerous diseases provides new means of curing patients with oncologic illnesses. There are several approaches in treating cancer by gene therapy. Most commonly used methods are: cancer immunogene therapy, suicide gene therapy, application of tumor-suppressor genes, antiangiogenic therapy, mesenchymal stem cells used as vectors, gene directed enzyme/prodrug therapy and bacteria used as anti-cancer agents. Cancer gene immunotherapy uses several immunologic agents for the purpose of explaining effective anti-tumor immune response. Another method is suicide gene therapy, based on introducing viral or bacterial agents to tumor cells, allowing the conversion of a non-toxic compound to a lethal medication. The application of intact suppressor genes to cancer cells will avert their neoplastic behavior and will induce tumor regression. Inhibition of angiogenesis is also a promising strategy for treating oncologic patients. Mesenchymal stem cells can also be used as vectors in targeted gene therapy. An increasing list of experimental evidence shows, that therapeutically modified mesenchymal stem cells in “gene directed enzyme/prodrug therapy” can attack cancer tissue can kill tumor cells, cancer stem cells included. Bacteria are used as anti-cancer agents independently of in combination with conventional therapeutic methods.
Authors and Affiliations
Valenčáková A. , Dziaková A. , Hatalová E.
EFFECT OF METHOD OF PREPARATION ON CHITOSAN MICROSPHERES OF MEFENAMIC ACID
Mefenamic acid loaded chitosan microspheres were prepared both by thermal and gluteraldehyde cross linking methods and high level of entrapment of Mefenamic acid was obtained in gluteraldehyde cross linking method. The m...
ENHANCED PERCUTANEOUS PERMEABILITY OF ACYCLOVIR BY DMSO FROM TOPICAL GEL FORMULATION
The aim of this study was to investigate the effect of DMSO on the permeation of acyclovir in the form of topical gel formulations. Different formulations were prepared containing carbopol 934P, acyclovir (1 % w/w) and s...
SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND RABEPRAZOLE BY HIGH PERFORMANCE LIQIUD CHROMATOGRAPHIC METHOD IN COMBINED DOSAGE FORMS
A simple, accurate and reproducible HPLC method have been developed for simultaneous estimation of Diclofenac sodium and rabeprazole from their tablets formulations. A phenomenex C18 (Luna) column of length 250×7.5...
VOMITING IS A POTENTIAL ADVERSE DRUG REACTION FOR LEVOMILNACIPRAN
Levomilnacipran is a drug used to treat depression. Micro Labs is a generic drug company which had developed an extended release formulation of Levomilnacipran 120 mg capsule. Two studies were conducted to assess the saf...
NEUROINFLAMMATION IN ALZHEIMER’S DISEASE AND INVOLVEMENT OF INTERLEUKIN-1: A MECHANISTIC VIEW
Ageing is a universal biological fact and a natural process. It begins from the day we are born, or perhaps even before. Of the world’s 580 million elderly, 77 million (22% of total) live in India. The increasing life ex...